S&P 500   4,690.65 (+2.16%)
DOW   35,755.95 (+1.50%)
QQQ   397.89 (+3.03%)
AAPL   170.81 (+3.32%)
MSFT   334.97 (+2.69%)
FB   323.75 (+1.85%)
GOOGL   2,937.84 (+2.61%)
AMZN   3,540.85 (+3.31%)
TSLA   1,045.05 (+3.57%)
NVDA   321.00 (+6.87%)
BABA   125.16 (+1.26%)
NIO   33.18 (+2.60%)
CGC   10.84 (+6.80%)
AMD   144.86 (+4.17%)
GE   98.06 (+2.14%)
MU   86.63 (+5.07%)
T   23.11 (-0.73%)
F   19.92 (+3.64%)
DIS   150.43 (+0.04%)
PFE   51.43 (-0.10%)
AMC   31.18 (+8.30%)
ACB   6.43 (+7.71%)
BA   210.95 (+2.46%)
S&P 500   4,690.65 (+2.16%)
DOW   35,755.95 (+1.50%)
QQQ   397.89 (+3.03%)
AAPL   170.81 (+3.32%)
MSFT   334.97 (+2.69%)
FB   323.75 (+1.85%)
GOOGL   2,937.84 (+2.61%)
AMZN   3,540.85 (+3.31%)
TSLA   1,045.05 (+3.57%)
NVDA   321.00 (+6.87%)
BABA   125.16 (+1.26%)
NIO   33.18 (+2.60%)
CGC   10.84 (+6.80%)
AMD   144.86 (+4.17%)
GE   98.06 (+2.14%)
MU   86.63 (+5.07%)
T   23.11 (-0.73%)
F   19.92 (+3.64%)
DIS   150.43 (+0.04%)
PFE   51.43 (-0.10%)
AMC   31.18 (+8.30%)
ACB   6.43 (+7.71%)
BA   210.95 (+2.46%)
S&P 500   4,690.65 (+2.16%)
DOW   35,755.95 (+1.50%)
QQQ   397.89 (+3.03%)
AAPL   170.81 (+3.32%)
MSFT   334.97 (+2.69%)
FB   323.75 (+1.85%)
GOOGL   2,937.84 (+2.61%)
AMZN   3,540.85 (+3.31%)
TSLA   1,045.05 (+3.57%)
NVDA   321.00 (+6.87%)
BABA   125.16 (+1.26%)
NIO   33.18 (+2.60%)
CGC   10.84 (+6.80%)
AMD   144.86 (+4.17%)
GE   98.06 (+2.14%)
MU   86.63 (+5.07%)
T   23.11 (-0.73%)
F   19.92 (+3.64%)
DIS   150.43 (+0.04%)
PFE   51.43 (-0.10%)
AMC   31.18 (+8.30%)
ACB   6.43 (+7.71%)
BA   210.95 (+2.46%)
S&P 500   4,690.65 (+2.16%)
DOW   35,755.95 (+1.50%)
QQQ   397.89 (+3.03%)
AAPL   170.81 (+3.32%)
MSFT   334.97 (+2.69%)
FB   323.75 (+1.85%)
GOOGL   2,937.84 (+2.61%)
AMZN   3,540.85 (+3.31%)
TSLA   1,045.05 (+3.57%)
NVDA   321.00 (+6.87%)
BABA   125.16 (+1.26%)
NIO   33.18 (+2.60%)
CGC   10.84 (+6.80%)
AMD   144.86 (+4.17%)
GE   98.06 (+2.14%)
MU   86.63 (+5.07%)
T   23.11 (-0.73%)
F   19.92 (+3.64%)
DIS   150.43 (+0.04%)
PFE   51.43 (-0.10%)
AMC   31.18 (+8.30%)
ACB   6.43 (+7.71%)
BA   210.95 (+2.46%)
NASDAQ:AEMD

Aethlon Medical Stock Forecast, Price & News

$2.33
+0.25 (+12.02%)
(As of 12/7/2021 11:48 AM ET)
Add
Compare
Today's Range
$2.18
$2.33
50-Day Range
$2.08
$4.23
52-Week Range
$1.45
$12.49
Volume
5,290 shs
Average Volume
2.34 million shs
Market Capitalization
$35.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.54
30 days | 90 days | 365 days | Advanced Chart
Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.


Aethlon Medical logo

About Aethlon Medical

Aethlon Medical, Inc. is a medical technology company, which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
8
Year Founded
N/A

Sales & Book Value

Annual Sales
$660 thousand
Book Value
$1.49 per share

Profitability

Net Income
$-7.89 million
Net Margins
-954.60%
Pretax Margin
-955.15%

Debt

Price-To-Earnings

Miscellaneous

Free Float
15,217,000
Market Cap
$35.88 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/09/2021
Today
12/07/2021
Next Earnings (Estimated)
2/09/2022
Fiscal Year End
3/31/2022

MarketRank

Overall MarketRank

1.78 out of 5 stars

Medical Sector

867th out of 1,394 stocks

Surgical & Medical Instruments Industry

93rd out of 126 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

Is Aethlon Medical a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aethlon Medical stock.
View analyst ratings for Aethlon Medical
or view top-rated stocks.

How has Aethlon Medical's stock been impacted by COVID-19 (Coronavirus)?

Aethlon Medical's stock was trading at $1.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AEMD shares have increased by 17.1% and is now trading at $2.33.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 201,400 shares, a decrease of 29.1% from the October 31st total of 284,000 shares. Based on an average daily trading volume, of 1,900,000 shares, the days-to-cover ratio is presently 0.1 days.
View Aethlon Medical's Short Interest
.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Aethlon Medical
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) released its earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.02. The medical equipment provider earned $0.13 million during the quarter, compared to analysts' expectations of $0.21 million. Aethlon Medical had a negative trailing twelve-month return on equity of 51.55% and a negative net margin of 954.60%. During the same period in the prior year, the business earned ($0.15) earnings per share.
View Aethlon Medical's earnings history
.

What price target have analysts set for AEMD?

2 brokerages have issued twelve-month target prices for Aethlon Medical's stock. Their forecasts range from $9.00 to $11.00. On average, they anticipate Aethlon Medical's share price to reach $10.00 in the next year. This suggests a possible upside of 329.2% from the stock's current price.
View analysts' price targets for Aethlon Medical
or view top-rated stocks among Wall Street analysts.

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:
  • Charles J. Fisher, Chief Executive Officer & Director
  • James B. Frakes, Chief Financial & Principal Accounting Officer
  • Annette Marleau, Research Director
  • Steven LaRosa, Chief Medical Officer
  • Guy F. Cipriani, Director, Chief Business Officer & Senior VP

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.89%), Dimensional Fund Advisors LP (0.67%), BlackRock Inc. (0.47%), Renaissance Technologies LLC (0.33%), Citadel Advisors LLC (0.00%) and Bank of New York Mellon Corp (0.19%).
View institutional ownership trends for Aethlon Medical
.

Which institutional investors are buying Aethlon Medical stock?

AEMD stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, BlackRock Inc., Renaissance Technologies LLC, Citadel Advisors LLC, Geode Capital Management LLC, Bank of New York Mellon Corp, Jane Street Group LLC, and HAP Trading LLC.
View insider buying and selling activity for Aethlon Medical
or or view top insider-buying stocks.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $2.33.

How much money does Aethlon Medical make?

Aethlon Medical has a market capitalization of $35.88 million and generates $660 thousand in revenue each year. The medical equipment provider earns $-7.89 million in net income (profit) each year or ($0.64) on an earnings per share basis.

How many employees does Aethlon Medical have?

Aethlon Medical employs 8 workers across the globe.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is www.aethlonmedical.com.

Where are Aethlon Medical's headquarters?

Aethlon Medical is headquartered at 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at [email protected].


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.